Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Interfering with Interferons: A Critical Mechanism for Critical COVID-19 Pneumonia
Helen C. Su, Huie Jing, Yu Zhang, et al.
Annual Review of Immunology (2023) Vol. 41, Iss. 1, pp. 561-585
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children
Paul Bastard, Adrian Gervais, Maki Taniguchi, et al.
The Journal of Experimental Medicine (2024) Vol. 221, Iss. 2
Open Access | Times Cited: 22
Human autoantibodies neutralizing type I IFNs: From 1981 to 2023
Paul Bastard, Adrian Gervais, Tom Le Voyer, et al.
Immunological Reviews (2024) Vol. 322, Iss. 1, pp. 98-112
Open Access | Times Cited: 20
Diabetes Mellitus, Energy Metabolism, and COVID-19
Caterina Conte, Elisa Cipponeri, Michael Roden
Endocrine Reviews (2023) Vol. 45, Iss. 2, pp. 281-308
Open Access | Times Cited: 15
Coronavirus disease 2019 (COVID-19) pandemic and autoimmune rheumatic diseases: Outcomes and prospects
Е. Л. Насонов
Rheumatology Science and Practice (2024) Vol. 62, Iss. 1, pp. 32-54
Open Access | Times Cited: 5
Establishment and application of a wild neonatal mouse model infected with an Echovirus 30 isolate
Ying Qu, Jing Wang, Yongbei Chen, et al.
Virology Journal (2025) Vol. 22, Iss. 1
Open Access
Life-threatening infections in human newborns: Reconciling age-specific vulnerability and interindividual variability
A. Borghesi
Cellular Immunology (2024) Vol. 397-398, pp. 104807-104807
Closed Access | Times Cited: 3
Yin and yang of interferons: lessons from the coronavirus disease 2019 (COVID-19) pandemic
Sara Svensson Akusjärvi, Ivan Zanoni
Current Opinion in Immunology (2024) Vol. 87, pp. 102423-102423
Closed Access | Times Cited: 3
Immune profiling of age and adjuvant-specific activation of human blood mononuclear cells in vitro
Simone Schüller, Soumik Barman, Raúl Méndez-Giráldez, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 3
Autoantibodies neutralizing type I IFNs underlie severe tick-borne encephalitis in ∼10% of patients
Adrian Gervais, Astrid Marchal, Andrea Fořtová, et al.
The Journal of Experimental Medicine (2024) Vol. 221, Iss. 10
Open Access | Times Cited: 3
Interferons—Implications in the Immune Response to Respiratory Viruses
Harrison C. Bergeron, Matthew R. Hansen, Ralph A. Tripp
Microorganisms (2023) Vol. 11, Iss. 9, pp. 2179-2179
Open Access | Times Cited: 8
The inflammatory microenvironment of the lung at the time of infection governs innate control of SARS-CoV-2 replication
Paul J. Baker, Andrea C. Bohrer, Ehydel Castro, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Interferon-stimulated genes and their antiviral activity against SARS-CoV-2
Ana María Ortega-Prieto, Jose M. Jimenez-­Guardeño
mBio (2024) Vol. 15, Iss. 9
Open Access | Times Cited: 2
Insights from CTTACC: immune system reset by cellular therapies for chronic illness after trauma, infection, and burn
Kenneth Bertram, Charles Cox, Hasan B. Alam, et al.
Cytotherapy (2024) Vol. 26, Iss. 7, pp. 714-718
Closed Access | Times Cited: 1
Salivary autoantibodies to type I IFNs: Mirror plasma levels, predispose to severe COVID-19, and enhance feasibility for clinical screening
Narjes Saheb Sharif‐Askari, Fatemeh Saheb Sharif‐Askari, Ola Salam Bayram, et al.
Heart & Lung (2024) Vol. 66, pp. 31-36
Closed Access | Times Cited: 1
Interferon-I Modulation and Natural Products: Unraveling Mechanisms and Therapeutic Potential in Severe COVID-19
Yuheng Song, Jiani Lu, Pengcheng Qin, et al.
Cytokine & Growth Factor Reviews (2024)
Closed Access | Times Cited: 1
Determinants of COVID-19 Disease Severity–Lessons from Primary and Secondary Immune Disorders including Cancer
Antonio Giovanni Solimando, Max Bittrich, Endrit Shahini, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8746-8746
Open Access | Times Cited: 3
Human genetic and immunological determinants of SARS‐CoV‐2 and Epstein–Barr virus diseases in childhood: Insightful contrasts
Qiang Pan‐Hammarström, Jean‐Laurent Casanova
Journal of Internal Medicine (2023) Vol. 294, Iss. 2, pp. 127-144
Open Access | Times Cited: 2
Anticytokine Autoantibodies in Infectious Diseases: A Practical Overview
Rob J.W. Arts, Nico Janssen, Frank L. van de Veerdonk
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 515-515
Open Access | Times Cited: 2
Critical COVID-19 Unveils the Link between Viral Particle Blood Dissemination and Prolonged Type I Interferon
Kahina Saker, Marine Mommert, Guy Oriol, et al.
(2024)
Closed Access
Insight into the role of IRF7 in skin and connective tissue diseases
Lian Wang, Fengjuan Yang, Jing Ye, et al.
Experimental Dermatology (2024) Vol. 33, Iss. 5
Closed Access
Human genetic and immunological determinants of SARS-CoV-2 infection and multisystem inflammatory syndrome in children
Halima Kholaiq, Yousra Abdelmoumen, Abderrahmane Moundir, et al.
Clinical & Experimental Immunology (2024)
Closed Access
The adaptive immune responses to SARS-CoV-2 as a recall response susceptible to immune imprinting
Daniel Álvarez‐Sierra, Mónica Martínez‐Gallo, Adrián Sánchez‐Montalvá, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Autoantibodies targeting interferons and GM-CSF are associated with adverse outcome risk, comorbidities, and pathogen in community-acquired pneumonia
Jakob Hjorth von Stemann, Arnold Matovu Dungu, M Laguarda, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
The inflammatory microenvironment of the lung at the time of infection governs innate control of SARS-CoV-2 replication
Paul J. Baker, Andrea C. Bohrer, Ehydel Castro, et al.
Science Immunology (2024) Vol. 9, Iss. 102
Open Access
A common form of dominant human IFNAR1 deficiency impairs IFN-α and -ω but not IFN-β-dependent immunity
Fahd Al Qureshah, Jérémie Le Pen, Nicole A. de Weerd, et al.
The Journal of Experimental Medicine (2024) Vol. 222, Iss. 2
Open Access
Page 1 - Next Page

Scroll to top